| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.52 | 0.06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |